A leading health expert has called for a coordinated national strategy to advance personalised medicine in Nigeria, highlighting its potential to revolutionize patient care and optimize treatment outcomes.
Speaking at a virtual webinar hosted by SYNLAB Nigeria, the expert emphasized that personalised medicine—an approach that tailors treatment to a patient’s unique genetic makeup, lifestyle, and environment—represents the future of healthcare.
The session, themed “Precision and Personalization: The Future of Medicine in Nigeria,” brought together medical professionals, researchers, and policymakers to explore how precision diagnostics and data-driven treatment can improve clinical outcomes.
SYNLAB, a leading medical diagnostics provider in Nigeria, reiterated its commitment to bringing advanced molecular diagnostics to the forefront.
“We are investing in local capacity and infrastructure to ensure Nigerians benefit from global advances in genomics,” said a SYNLAB spokesperson.
SYNLAB’s initiatives include:
With the rising burden of non-communicable diseases such as cancer, diabetes, and cardiovascular illnesses, the traditional one-size-fits-all treatment model is becoming less effective.
Personalised medicine enables:
“Imagine cancer treatment designed specifically for your genetic profile—this is not the future, it’s already here,” the expert concluded.